The AUCs for AD versus SCD were excellent for p‐tau217/Aβ42, all p‐tau isoforms, GFAP, and NfL, as well as for biomarker combinations (AUCs > 0.916; Table S7 in supporting information). This evidence concerns the gene MAPT and Alzheimer disease.